These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25478774)

  • 21. Liver function considerations for post-selective internal radiation therapy resection (hepatocellular carcinoma and metastatic colorectal cancer).
    Sangro B
    Future Oncol; 2014 Nov; 10(15 Suppl):57-9. PubMed ID: 25478769
    [No Abstract]   [Full Text] [Related]  

  • 22. Ongoing selective internal radiation therapy-based studies in the treatment of liver-dominant metastatic colorectal cancer.
    Heinemann V
    Future Oncol; 2014 Nov; 10(15 Suppl):37-9. PubMed ID: 25478765
    [No Abstract]   [Full Text] [Related]  

  • 23. Reply to: "Pre-therapeutic dosimetry evaluation and selective internal radiation therapy of hepatocellular carcinoma using yttrium-90-loaded microspheres".
    Sangro B; Iñarrairaegui M; Bilbao JI
    J Hepatol; 2013 May; 58(5):1056-7. PubMed ID: 23321319
    [No Abstract]   [Full Text] [Related]  

  • 24. Bridging and downstaging to transplantation in hepatocellular carcinoma.
    Ettorre GM; Levi Sandri GB; Santoro R; Lepiane P; Colasanti M; Vennarecci G
    Future Oncol; 2014 Nov; 10(15 Suppl):61-3. PubMed ID: 25478770
    [No Abstract]   [Full Text] [Related]  

  • 25. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk.
    Crook JM; Potters L; Stock RG; Zelefsky MJ
    Brachytherapy; 2005; 4(3):186-94. PubMed ID: 16182218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors and prevention of radioembolization-induced liver disease.
    Gil-Alzugaray B; Chopitea A; Iñarrairaegui M; Bilbao JI; Rodriguez-Fraile M; Rodriguez J; Benito A; Dominguez I; D'Avola D; Herrero JI; Quiroga J; Prieto J; Sangro B
    Hepatology; 2013 Mar; 57(3):1078-87. PubMed ID: 23225191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver metastases from neuroendocrine tumors.
    Kennedy A
    Future Oncol; 2014 Nov; 10(15 Suppl):83-7. PubMed ID: 25478775
    [No Abstract]   [Full Text] [Related]  

  • 28. Selective internal radiation therapy: validation of intraoperative dosimetry.
    Burton MA; Gray BN; Kelleher DK; Klemp PF
    Radiology; 1990 Apr; 175(1):253-5. PubMed ID: 2315490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Y90 selective internal radiation therapy.
    Lee EW; Thakor AS; Tafti BA; Liu DM
    Surg Oncol Clin N Am; 2015 Jan; 24(1):167-85. PubMed ID: 25444474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yttrium-90 radioembolization of malignant tumors of the liver: gallbladder effects.
    Sag AA; Savin MA; Lal NR; Mehta RR
    AJR Am J Roentgenol; 2014 May; 202(5):1130-5. PubMed ID: 24758670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics.
    Salem R; Thurston KG
    J Vasc Interv Radiol; 2006 Sep; 17(9):1425-39. PubMed ID: 16990462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Selective internal radiotherapy for advanced liver tumors and metastases].
    Hoffmann RT; Jakobs TF; Tatsch K; Reiser MF
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2099-102. PubMed ID: 18814106
    [No Abstract]   [Full Text] [Related]  

  • 33. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma.
    Welsh JS; Kennedy AS; Thomadsen B
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S62-73. PubMed ID: 16979443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].
    Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G
    Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe coagulopathy after 90Y microsphere administration: resemblance to the Kasabach-Merritt syndrome.
    Hoffman MA; Rubin JI; Vinceguerra VP; Nowakowski FS; Warner RR
    J Vasc Interv Radiol; 2008 Jul; 19(7):1099-102. PubMed ID: 18589326
    [No Abstract]   [Full Text] [Related]  

  • 36. Underlying liver disease influences volumetric changes in the spared hemiliver after selective internal radiation therapy with 90Y in patients with hepatocellular carcinoma.
    Teo JY; Goh BK; Cheah FK; Allen JC; Lo RH; Ng DC; Goh AS; Khor AY; Sim HS; Ng JJ; Chow PK
    J Dig Dis; 2014 Aug; 15(8):444-50. PubMed ID: 24828952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation-Induced Liver Disease and Modern Radiotherapy.
    Koay EJ; Owen D; Das P
    Semin Radiat Oncol; 2018 Oct; 28(4):321-331. PubMed ID: 30309642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evidence for resection post-selective internal radiation therapy.
    Garlipp B; Bruns CJ
    Future Oncol; 2014 Nov; 10(15 Suppl):49-52. PubMed ID: 25478767
    [No Abstract]   [Full Text] [Related]  

  • 39. A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres.
    Chiesa C; Mira M; Maccauro M; Romito R; Spreafico C; Sposito C; Bhoori S; Morosi C; Pellizzari S; Negri A; Civelli E; Lanocita R; Camerini T; Bampo C; Carrara M; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):503-8. PubMed ID: 23358402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective internal radiation therapy: a case of SIR-Sphere associated duodenal ulceration.
    Newland LR; Walsh A; Gilbert DR; Buckland ME
    Pathology; 2007 Oct; 39(5):526-8. PubMed ID: 17886108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.